4//SEC Filing
MIRAGEN THERAPEUTICS, INC. 4
Accession 0001209191-17-023165
$VRDNCIK 0001590750operating
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 5:15 PM ET
Size
8.0 KB
Accession
0001209191-17-023165
Insider Transaction Report
Form 4
Hughes Thomas E.
Director
Transactions
- Award
Stock Option (right to buy)
2017-03-24+1,191→ 1,191 totalExercise: $11.80Exp: 2027-03-23→ Common Stock (1,191 underlying) - Award
Common Stock
2017-03-24+778→ 14,840 total
Footnotes (2)
- [F1]Grant to the Reporting Person of a restricted stock award under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in three equal quarterly installments beginning on April 1, 2017 through December 31, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan.
- [F2]Grant to the Reporting Person of a stock option under the Plan. The shares vest in three equal quarterly installments beginning on April 1, 2017 through December 31, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The option expires 10 years after the date of grant.
Documents
Issuer
MIRAGEN THERAPEUTICS, INC.
CIK 0001590750
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001590750
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 5:15 PM ET
- Size
- 8.0 KB